Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al

$25.00
In stock
SKU
v14i3porter
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Downloadable
More Information
Authors Stenan D. Porter
Classification Antitrust
Write Your Own Review
You're reviewing:Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
Your Rating
Copyright © 2014 - 2022 American Academy of Economic and Financial Experts. All Rights Reserved. Designed and Developed by Larry Havard, Havard Econometrics. All Rights Reserved